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Current architectural and production limitations prevent the manufacturing standardization, design, 
and reproducibility of bioceramics. Such limitations have hindered advances in bone tissue 
engineering and regeneration. In this context, we propose a bioceramic manufacturing process based 
on the impregnation of wax molds produced by additive manufacturing. Hydroxyapatite (HA) 
bioceramics with custom architectures were fabricated to evaluate the reliability, robustness and 
limitations of this process. Results indicate that this process preserves phase biocompatibility, 
permits homogeneous shrinkage of the biomaterial during heat treatment, and allows reproducible 
and precise manufacturing of custom architectures (e.g., 5 µm widths and high cusps for channels of 
200 µm with a 6 µm printer resolution). Therefore, the architectural opportunities offered by this 
process widely exceed its architectural limitations, indicating its potential for both therapeutic 
applications and fundamental research. 







Calcium phosphate (CaP) bioceramics have been used for years for therapeutic purposes [1] and for 
fundamental research. [2] The first type of applications is the development of bone substitutes for 
regenerative medicine (e.g., repair of small bone defects). The success of such a therapy is 
determined by the implant’s ability to interact positively with the host tissue (e.g., cell invasion, 
degradation and replacement). The second type of applications, i.e. fundamental research, focuses 
on understanding the fundamental aspects of bone biology and the assessment of drugs by 
developing in vitro models. This involves the development of scaffolds for the in vitro culture of cells 
in controlled three-dimensional (3D) environments. [3] 
For both therapeutic and 3D-scaffold-based culture strategies, the scaffold architecture may directly 
(e.g., nutrient transport, cell colonization) or indirectly (e.g., shear stress, local stimuli) influence the 
cell fate through its macroscopic (>100 µm) and microscopic (<20 µm) features. Numerous studies 
have investigated the influence of micro- and macro- architecture, both of which are of great 
importance (see for review). [3] However, an important disparity regarding the influence of the 
architecture on cell response and fate is present in the current literature as summarized in Bouet et 
al. [3] Such discrepancies are most likely due to the random internal pore architecture of the scaffolds, 
which is related to the limitations of current scaffold production methods. 
Until recently, CaP bioceramics have been primarily produced using traditional ceramic processing 
techniques. Depending on the intended applications, several approaches may be considered, 
including the use of CaP dry powders (e.g., pressing), [4] bulk materials (e.g., hydrothermal exchange, 
machining) [5] or suspensions. Suspension-based methods, such as porogen or salt leaching, [6] mold 
impregnation, [7] foaming, [8] or freeze drying, [9] are traditional and versatile processes for 
manufacturing of macroporous CaP scaffolds. [10] These conventional methods are relevant and allow 
the production of tuned scaffolds; however, they still suffer from architectural limitations (e.g., 
global/local shape), internal inhomogeneity (e.g., pore and interconnection size) and sample-to-
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sample variations (e.g., random pore distribution). This lack of architectural standardization prevents 
the rigorous design of biological experiments and limits their reproducibility. [3] 
New engineering developments that combine computational methods and additive manufacturing 
(AM) technologies are able to overcome such limitations by providing both a higher level of control 
over the design of the manufactured scaffolds and the opportunity to create reproducible, optimized 
custom architectures. AM technologies for bioceramics are far less advanced than for polymers and 
metals, [11] but prototypes or small batches of Al2O3/ZrO2 have been produced using 
stereolithography (SLA, e.g., Lithoz, Austria; Prodways, France), selective laser melting (SLM, e.g., 
Phenix systems, France) or 3D-printing (3DP, e.g., Center for Fine Print Research, UK) technologies. 
Technological development of AM methods for the production of CaP scaffolds is still in its early 
stages because of the challenging specifications of biological applications associated with the specific 
physicochemical [12] and thermal properties [13] of CaP. Thus, the AM process for the production of 
such CaP scaffolds should preserve CaP biocompatibility (no toxic residue), should not induce phase 
modifications, and should allow reproducible and precise manufacturing of a wide array of custom 
architectures (e.g., pore sizes from approximately 150 µm to 1 mm). Additional criteria, such as the 
AM machine costs and the flexibility and ease of implementation of the process must also be 
considered. 
CaP scaffolds produced via “direct-write assembly”, [14] including robocasting [15] or 3DP, [16] have 
been recently reported in the comprehensive reviews of Kumar et al. [17] The conclusion is that their 
applications are restricted due to the lack of architectural control at both the global and local scales 
and the architectural limitations inherent in these processes (e.g., arrangement of tubes more or less 
well-defined for “3D plotting”, [17b] accuracy of deposition and post-printing cleaning of the structures 
for 3DP). Craniofacial bone substitutes were successfully produced by SLA (3DCeram, France). [18] 
Nonetheless, apart from the high costs of such a technology, the SLA process involves the use of toxic 
monomers, [19] which may affect sensitive CaP phases, and lacks flexibility; especially because of the 
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difficulty in adapting the compositions of the highly concentrated ceramic suspensions [20] to various 
CaP phases. Finally, post-processing or post-fabrication issues, such as the removal of non-
polymerized slurry or, in some case, support structures, restrict the ceramic design possibilities.[17b, 21] 
Selective laser sintering (SLS) [22] and SLM [23] methods require further developments for the 
production of CaP scaffolds, primarily due to the low macro- and micro-architectural control and to 
phase degradation during the shaping process that is not compatible with the intended biological 
applications. Moreover, because these technologies use a laser beam or electron beam as the power 
source, they are expensive, and their use in research laboratories is limited. 
Considering the specifications and current limitations (listed above) for the production of CaP 
bioceramics, we utilizes an “indirect 3D printing” as defined in Do et al., [24] and more precisely a 
manufacturing process based on the impregnation of wax molds produced via an AM technology. 
This process already described in recent studies, [25] was here optimized in order to fabricate pure 
CaP porous bioceramics with a high level of control over the architecture. More precisely, in this 
paper, we focus on the determination of the robustness, architectural capabilities and limitations of 
such a process to produce HA bioceramic. Wax molds were produced using a 3D Drop on Demand 
(DoD) based 3D printer, followed by a traditional ceramic process of replication. The optimization of 
the ceramic processing is described elsewhere. [26] The influence of the wax mold printing strategy 
(e.g., orientation, resolution) on the micro- and macro- architectural features of the bioceramics was 
studied. Finally, the architectural reproducibility (e.g., shape conservation, sample-to-sample 
homogeneity) was assessed at the scaffold scale using triply periodic spherical structures with 8-mm 
diameters. 
2. Materials and Methods 
2.1. Ceramic Manufacturing process – Overview. 
The manufacturing process consists of three main stages.  
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The first stage is the computer-aided design (CAD) conception of the intended ceramic and its 
respective wax mold (Figure 1 A to C). The latter is designed as the negative of the bioceramic (i.e., 
the structure and internal voids of the mold will become the macropores and the ceramic part of the 
scaffold, respectively). For compatibility purposes with the AM machine, CAD files are exported in 
the stereolithography file format (.stl), which is an approximation of the original model using planar 
triangles via tessellation. The material deposition (print head path) is determined using a virtual 
orientation of the mold .stl file that is sliced into a stack of 2-dimensional (2D) layers based on a given 
layer thickness. Finally, the sliced file is sent to the AM machine for the production stage. 
The second stage is the production of the mold via additive manufacturing. A 3ZStudio 3D printer 
(Solidscape, Multistation, Paris) was selected because of its relatively low cost, high and adjustable 
resolution (from 6 µm to 25 µm) and compatibility of wax molds with the ceramic processing (i.e., 
low shrinkage, adapted thermal properties and no residue after debinding). [26] Molds were built 
layer by layer by depositing “build” and “support” molten wax droplets through outlet nozzles that 
harden immediately onto the piece under construction. The layer thickness is corrected using a 
milling head (Figure 1D). After the printing is completed, the part is placed in a 52°C bath of 
petroleum distillate (Onyx Ardéa, France) until the part is clean and all support material has been 
removed. Both the layer thickness and the mold printing orientation, shown in Figure 1 D to F, affect 
the mold features and, consequently, the resulting bioceramic. The effect of these parameters will be 
studied hereafter.  
The ceramic processing, presented in section 2.2 and described in detail in Charbonnier et al., [26] 
represents the final stage of the bioceramic production. Molds are impregnated with an aqueous 
suspension of CaP powder. After drying, the organic substances (e.g., wax mold, dispersing agent) are 
removed from the green material (debinding), which is then sintered to obtain the bioceramic. 
The bioceramic manufacturing process, from mould manufacturing to ceramic sintering, induces 
large (i.e., at the scaffold scale) or localized morphological deformations, which may be detrimental 
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to the bioceramic in terms of mechanical handling and/or compliance with specifications. Therefore 
the estimation of the morphological deviations of the produced bioceramics from their respective 
CAD models is required to validate this manufacturing process (see sections 2.3 and 2.4). 
2.2. Ceramic processing 
2.2.1 Powder synthesis 
HA powder was prepared via an aqueous precipitation method using a fully automated apparatus. A 
diammonium hydrogen phosphate ((NH4)2HPO4, 99%, Merck, Germany) solution was added drop-
wise to a calcium nitrate solution (Ca(NO3)2·4H2O, 99%, Merck, Germany) using peristaltic pumps. 
The reaction was performed under continuous stirring under reflux at a regulated temperature of 
45°C (external T-probe). An argon flow (Air Products, 0.1 L/min) in the reactor prevented any 
uncontrolled carbonation of precipitates. The pH of the suspension was automatically adjusted and 
maintained at 9.0 with a 28% ammonia solution (Merck, Germany) by mean of a pH stat (GALa 0420 
TTT, Prominent, Strasbourg, France). After the introduction of all of the reagents, the suspension was 
aged for 17 h and then filtered. The precipitate was pre-calcined at 400°C for 2 hours (Carbolite, UK) 
before it was crushed to a size of 1 to 10 µm (Hosokawa Alpine, AFG100, Germany). The HA powder 
was then heat-treated at 1020°C for 2 hours (LH40/13, Nabertherm, Germany) to obtain a surface 
area of 4.0 ± 0.1 m²/g (N=3). This value was determined on powders outgassed at 150°C for 8 h by 
means of the Brunauer-Emmett-Teller (BET) 5 points method using the N2 adsorption isotherm 
(Micromeritics ASAP 2010, Germany). 
 
2.2.2. Bioceramic scaffold preparation 
Templates were impregnated with a HA slurry prepared by blending 73.6% (w/w) powder, 26.2% 
(w/w) pure water and 0.2% (w/w) dispersing agent (Darvan C-N,R. T. Vanderbilt Company Inc., USA) 
for 15 min at 200 rpm in a zirconia jar with 10 and 5 mm diameter zirconia balls (PM400, Retsch, 
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Germany). An organic binder (Duramax B-1000, Rohmand Haas, France) was then added at a 
concentration of 3.7% (w/w of slurry). The slurry was then mixed for 15 min using a propeller stirrer. 
After drying overnight at room temperature, the green bodies were cleaned of all excess dried slurry 
using a surgical blade (Swann-Morton, UK). The green bodies were then heat-treated in a debinding 
furnace (Carbolite, UK) at a temperature of 500°C to eliminate the polymer mold and the organic 
adjuvants. The consolidation of the ceramic was achieved by sintering at 1200°C for 2 hours in air 
with a heating rate of 4°C/min (LH40/13, Nabertherm, Germany). 
 
2.3. Influence of mold printing parameters on ceramic architectural features 
A bioceramic CAD model with channels oriented along a single direction (Figure 1A) was designed to 
assess the influence of the mold printing parameters on the architectural features of the bioceramic. 
Circular and right-angled triangular (θ1=90°, θ2=45°) channels were defined with three different sizes 
according to macropore sizes reported in the literature: [3] small (≈ 200 µm), medium (≈ 400 µm) and 
large (≈ 800 µm). The dimensions of the round and triangular columns of the molds printed with 
resolutions of 6 µm, 12 µm and 25 µm along the z-axis (Figure 1E) or perpendicular to the printer x 
axis (Figure 1F) are presented in Figure 1. Bioceramics were obtained according to the process 
described in section 2.2. 
Morphometric analyzes of the produced bioceramics were carried out at various scales. Each 
bioceramic was first imaged using a Nanotom S X-ray computed tomography system (Phoenix, USA) 
with a voltage of 80 kV (tungsten target), an integration time of 750 ms and a 3.5 µm voxel 
resolution. For reconstruction of the volume data, a proprietary implementation based on the 
Feldkamps cone beam-reconstruction algorithm was used. VG Studio software (Volume Graphics, 
Heidelberg, Germany) was used for the 3D visualization of the volume data and the dataset export in 
.DICOM format for image analysis. The geometrical features of the bioceramic pores were analyzed 
in 2D on 3 cross-sections perpendicular to the channels at the inlet, middle and outlet of the 
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bioceramic using ImageJ freeware (National Institutes of Health, USA). A schematic representation 
for right-angled triangular channel is given in Figure 2. From these results, three morphological 
factors, aspect ratio (A.R.), form factor (F.F.), and roundness (R.) were calculated from the following 
Equations and in accordance with ISO norm 9276-6: 
. .= 	   (1) 
. .= 		
	×		×   (2) 
.= 		 
	×	×	  (3) 
with L and B the maximum and minimum Feret diameters (see Figure 2), respectively, and A and P 
the area and the perimeter of the channel, respectively. 
The theoretical values of the morphological factors A.R., F.F. and R. are equal to 1 for a circle, and 
0.50, 0.73 and 0.56 for isosceles right triangle, respectively. 
Scanning electron microscopy (SEM, JEOL JSM-6500F, USA) was used to image the internal geometry, 
microarchitecture and microstructure of the channels. Particular attention was given to the 
determination of the cusp depth (Hcusp) and spacing (Lcusp) inherent to the AM process (Figure 2). 
Prior to observation, the bioceramics were mounted in a thermoset epoxy resin (EpoThin, Buehler, 
USA), with both of their faces covered to prevent the resin from entering the channels. After 
mounting, samples were polished either parallel or perpendicular to the channels, using an 
automated polishing system (Prepamatic, Struers, Denmark). Polished samples were coated with 






2.4. Architectural control and reliability at the scaffold scale – Process validation 
The targeted applications for the bioceramic scaffolds require reproducible production of complex 
3D CaP scaffolds with a custom, controlled architecture. Consequently, the validation of our process 
requires an analysis of the architectural reliability at the scaffold scale. Spherical ceramics (8 mm 
diameter) with a triply periodic internal architecture (gyroid), were designed using the ScanIP 
software suite (Simpleware, UK) and then manufactured to evaluate (i) the reproducibility of the 
process, (ii) the conservation of the shapes at both the global and local scales, and (iii) the 
homogeneity of the internal architecture and microstructure (Images of the CAD model are provided 
in supplementary Figure 1). This triply periodic porous network is comprised of 540 µm diameter 
cavities with 330 µm diameter interconnections and 310 µm thick ceramic walls. An 850 µm gyroid 
unit cell was repeated over the entire sphere volume, resulting in a total porosity of 70%. A cylinder 
(Ø = 850 µm, h= 850 µm) and a cube (L = 850 µm) were inserted into the structure as visual markers 
for further geometric data analysis (see supplementary Figure 1). Molds were printed at a resolution 
of 6 µm and the HA bioceramics were produced in triplicate according to the process described in 
section 2.2. 
Morphometric analysis was performed using X-ray tomography (see Section 2.3). ScanIP suite was 
used for image data processing. The conservation of the spherical shape of the bioceramics was first 
analysed. To assess the shape conservation of the internal architecture over the entire sphere 
volume, cross-sections of the xy-, xz-, and yz- planes were compared to the CAD file to evaluate any 
deviations. The CAD model and the bioceramic 3D images were superimposed using the square and 







3.1. Influence of the mold printing parameters on the scaffold architectural features 
Figure 3 shows X-ray micro-tomography 3D images of the bioceramics and their respective cross 
sections obtained from molds printed with columns along (Figure 3A) or perpendicular (Figure 3B) to 
the z-axis of the printer (Figure 1). The printing orientation of the mold is visible on the ceramics 
printed at resolutions of 25 µm (images not included) and 12 µm (Figure 3), but is much less apparent 
for a printing resolution of 6 µm (images not included). A more detailed examination of these 
observations is presented in Section 3.1.  
At the macroscale, the bioceramics exhibit all 6 channels regardless of the manufacturing 
parameters. Despite cropping of the 90° angles, triangular shaped channels are sharper and better-
defined in bioceramics with channels perpendicular to the z-axis of the printer (Figure 3B), than in 
bioceramics with channels parallel to the z-axis of the printer (Figure 3A). In the latter, the vertices of 
the triangular shapes are rounded, so much so that the smallest triangle appears circular, regardless 
of the mold printing resolution. Circular shapes are generally well defined; however, a clear 
deformation is observed on the smallest circle in Figure 3B which appears as a square. 
These general observations are complemented by the analysis of the geometric characteristics and 
morphological factors displayed in Figures 4 and 5, respectively. 
In bioceramics produced from molds with columns aligned along the z-axis of the printer (Figures 3A 
and 4A), the diameter of the circular channels (Figure 4A1) changes slightly from sample to sample, 
with a maximum deviation of 15 µm, but evolves with the resolution. For instance, the diameter of 
the smallest channel decreases from 232 to 192 µm as the resolution increases from 25 to 6 µm. In 
contrast, when the mold is printed with columns perpendicular to the z-axis of the printer (Figures 3B 
and 4B), there is no significant variation in the bioceramics channel diameter regardless of the 
resolution. Thus, the diameters of small, medium and large circular channels are centered at 195, 
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425 and 820 µm with a maximum standard deviation of 10 µm. Conservation of angles in the 
triangular channels compared to the CAD model is highly dependent on the triangle size as well as 
the printing orientation of the molds. For bioceramics produced from molds with columns along the 
z-axis of the printer (Figure 4A2-A3), no angle was measured on the smallest triangle due to its 
circular shape, but the medium and large triangles exhibit relatively good angular conservation (e.g., 
43.6°, 45.0° and 45.0° for large triangles with a 25, 12 and 6 µm resolution). The standard deviation 
decreases with increased triangle size: non-measurable, ± 1.1, ± 0.5° for 45 ° angles of small, medium 
and large triangles, respectively. Moreover, the angle variation, with regard to the theoretical values 
(45° or 90°), narrows slightly with an increase in the printing resolution (e.g., ± 1.15° > ± 1.1° > ± 1.05° 
for 25, 12 and 6 µm resolution, respectively, for medium triangle 45° angles). These observations 
remain mostly valid for the bioceramics produced from molds with columns perpendicular to the z-
axis of the printer, with two differences (Figure 4B2-B3). First, there is better conservation of the 
angles in the smallest triangle. Although the angles are 82 ± 1.3° and 48.5 ± 0.9° instead of 90° and 
45° angles, respectively, we were able to measure these angles unlike in the bioceramics produced 
from molds with columns along the z-axis of the printer. Second, there is better angular control 
because the standard deviation and angular variation are lower for both the medium and the large 
triangles (i.e., 47.3 ± 0.6°, 45.4 ± 0.6° and 45.5 ± 05° for resolutions of 25, 12 and 6 µm, respectively, 
for the 45° angles in the medium triangle). 
Aspect ratios, roundness, and form factors for the triangular and circular channels are displayed in 
Figure 5 for each set of manufacturing parameters. 
For bioceramics manufactured from molds with columns both along and perpendicular to the z-axis 
of the printer, the aspect ratio is close to its theoretical value for the medium and large channels 
regardless of the shape (triangular or circular). A deviation from the theoretical value is observed for 
the small circular and triangular channels. This deviation slightly decreases with increased printing 
resolution. Channel roundness follows a similar trend with the exception of the triangular channels of 
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the bioceramics produced from molds printed with columns perpendicular to the z-axis of the 
printer, which have roundness values that match the theoretical values regardless of channel size. 
Finally, the form factor matches or is close to its theoretical value regardless of the shape of the 
channels and the printing orientation of the mold. An exception to this trend can be observed for the 
circular channels of the bioceramics produced from molds with columns perpendicular to the z-axis 
of the printer. Finally, when molds are printed with columns perpendicular to the z-axis, the form 
factors of the bioceramics channels approach the theoretical values as the resolution increases. 
Figure 6 shows SEM images of cross-sections of the circular channels for both mold printing 
directions. The images show the layer-by-layer structure of the bioceramic induced by the mold 
topology.  
The 25 µm layer resolution resulted in a surface topology on the produced bioceramic with Hcusp = 
19.8 ± 3.0 µm and Lcusp = 20.7 ± 1.9 µm. Likewise, using a 12 µm 3D printer resolution, the 
bioceramics exhibit a surface topology with Hcusp = 9.6 ± 1.0 µm and Lcusp = 9.2 ± 1.9 µm. For a 6 µm 
resolution, the layer-by-layer and well-defined micro-architecture tend to blur, with cusps 
approximately 5 µm wide and high, which sometimes merge to form broader grooves (Figure 6C). 
Furthermore, as the resolution increases, the channel surfaces become less jagged-looking and are 
more linear (images not included). Similar conclusions can be drawn for the bioceramics with 
channels perpendicular to the z-axis of the printer (Figure 6 D to F). The staircase morphology, 
observed for a 25 µm resolution, becomes smoother as the resolution increases. 
 
3.2. Process robustness at the scaffold scale 
Figure 7A displays an X-ray micro-tomography 3D image of the triply periodic bioceramic. The 
spherical shape is preserved, with an apparent shrinkage of 14.5 ± 0.8%. At a local scale, the internal 
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architecture is also maintained and does not undergo any inhomogeneous deformation with a wall 
shrinkage of 14.1 ± 2.7% (Figure 7B). 
The similarities between the bioceramic CAD model and the produced bioceramic are assessed 
(Figure 7C). Despite a lack of overlapping areas, especially at the edge of the ceramic, the gyroid 
shape is maintained over the entire sphere volume. The lack of overlapping areas may be explained 
by (i) the removal of excess material during the cleaning step of greens (see Section 2.2.2), and (ii) 
software limitations for 3D image fitting (e.g., maximal angular accuracy of 1°). 
 
4. Discussion 
In this work, we validated the manufacturing of CaP bioceramics with complex and controlled 
architectures via the impregnation of 3D-printed wax molds. The macroporous 3D networks are 
reproducible with a large amount of control at both the global and local scales (Section 3.2). Despite 
a high consistency between the produced 3D bioceramics and their respective CAD models, 
deviations in the construct surface may be observed. This was confirmed by the geometrical analysis 
performed at the pore scale (section 3.1). The shapes of the unidirectional channels were generally 
well-defined and the highest geometrical accuracy (with respect to angle) and dimensional reliability 
were achieved in bioceramics produced using molds with columns perpendicular to the z-axis of the 
printer. An increase in the layer resolution from 25 to 6 µm significantly reduced the channel 
roughness (Figure 6). Nonetheless, shape deformations were not completely avoided (e.g., rounded 
edges or cropping of the 90° angle of the triangles, see Section 3.1). 
Some possible causes were identified to explain bioceramics architectural deviations from the CAD 
model: (i) issues during ceramic processing, (ii) inappropriate mold printing strategy, (iii) 
approximations in the .stl export of the mold CAD model or inaccuracy in the .stl file slicing, and (iv) 
technological limitations of the 3D printer. 
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Ceramic processing (i.e., mold cleaning, impregnation and heat treatments) is not responsible for the 
differences between the bioceramic and its CAD model because the slurry formulation used herein 
was proved to be suitable for the developed process without generating post-sintering defects (i.e., 
homogeneous and isotropic shrinkage). [26] Furthermore, complementary X-ray micro-tomography 
scans of the molds revealed similar deformation at both the mold and bioceramic surfaces. Finally, 
no wax residue or dust was observed in the mold, suggesting that the defects observed on the 
bioceramic surface are related to mold topology. This is supported by the fact that the shape 
deformations are specific to the mold printing parameters, and primarily a function of the mold 
printing orientation. In fact, the mold printing resolution affects the surface morphology more than 
the geometrical features (i.e., shapes, see Figure 2). In addition, for a given printing orientation, the 
architectural features are affected to different extents depending on their geometry (e.g., angles 
versus curves) and dimensions (e.g., small versus large channels). These trends are consistent with 
the technological challenges of 3D-printing based technologies as stated by Oropallo et al. [19b] The 
choice of a printing orientation appears to be a compromise between part design and one or more 
manufacturing considerations such as printing time, cost or geometrical accuracy. [27] Thus, the more 
specifications required for a part, the more compromises required. It is also crucial to note that 
depending on the part design, “there may not be an optimal orientation that meets the needs of the 
design”. [19b] This need for a printing strategy emphasizes the current limitations of AM processes, 
including computational methods (e.g., CAD file, tessellation). 
It is generally accepted that the tessellation algorithms used for the export of the CAD model in .stl 
file can generate geometric errors, especially if the model contains curved surfaces. [28] In our case, 
this has a minor impact as no facet or chordal error was observed on either the ceramics or the 
molds. Additionally, the .stl file slicing can lead to architectural deviations between the bioceramic 
and its CAD model. For columns printed along the z-axis of the printer, the CAD model is maintained 
after slicing (i.e., triangles keep sharp angles without deformation regardless of their size and circles 
undergo minor polygonal approximations). In the worst-case scenario, that of the smallest circle, this 
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approximation produces an 18-sided polygon (side length of approximately 36.8 µm) with a mean 
diameter of 209.4 ± 0.5 µm rather than 220 µm (theoretical value). Conversely, for an orientation of 
columns perpendicular to the z-axis of the printer, the .stl file slicing results in cropping of the 90° 
angles, lightly flattened surfaces at the circle extremities (top and bottom) and staircase 
morphologies at the construct surfaces. Similar deformations are observed on the molds and the 
bioceramics. An example of the imperfections is illustrated in Table 1 with a comparison, at different 
production stages, of the flattened surfaces on the flat-topped triangles. For more precision, please 
refer to the supplementary Figure 2. 
This cross-analysis (Table 1) clearly indicates that the slicing procedure is not the most significant 
cause of geometrical deviation from the CAD models. Even though the flattened surfaces measured 
on sliced and micro-tomography images are of the same order of magnitude (hundred micrometers), 
the flattened surfaces of the molds are, on average, 39.4 ± 11.9% wider than in the sliced .stl files. 
This suggests that the DoD technology is the predominant limiting factor.  
As presented briefly in section 2.1, the mold is fabricated layer by layer, alternating between waxes 
deposition through outlet nozzles and correction of the layer thickness with a milling head. No 
significant shape deformation based on the milling direction was detected on the molds or the 
bioceramics. Thus, the technological limitations of the 3D printer are due to the wax deposition, 
more specifically to the variation of droplet size (Δd), droplet position (Δp), and droplet spreading on 
the material (Δs average diameter of the splashed droplet after deposition) as presented in Figure 8. 
These variations are a function of the frequency of the piezo-electric component (Δƒ) inside the print-
head, the print-head and operating temperatures (ΔT), and the print head position and momentum. 
[29] All these technical wax deposition issues result in variations of ± 17.1% in the deposit width (see 
Figure 8) for a single straight line monolayer (2.5 mm length, N = 30). This is consistent with the 
inaccuracies observed in the molds with unidirectional columns and their resulting bioceramics, 
independent of the printing parameters. 
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Overcoming the current technological limits of the 3D printer through better control of the droplet 
size and deposition would improve this ceramic manufacturing method. Optimization of the 
proprietary slicing and print head path planning algorithms may also be required. Finally, the process 
limitations and possible printing strategies must be integrated into the ceramic design to allow 
compromises that are compatible with the intended applications. Currently, part design options are 
constrained by technological limitations but in the future, AM technologies may support better part 
design and lead to new scientific insight. However, for the current applications, the developed 
manufacturing process is far more accurate than conventional or current AM (e.g., direct-write 
assembly, SLS) ceramic processing methods and convenient enough for the production of custom 
bioceramics adapted to fundamental and therapeutic applications. Figure 9 illustrates the potential 




The goal of this study was to evaluate the reliability, robustness and limitations of a bioceramic 
manufacturing process based on the impregnation of additively manufactured molds. The results 
suggest that the architectural deviations observed between the CAD model and the bioceramic are 
primarily due to the technical limitations of the 3D printer, more specifically to the variability of the 
wax droplet deposition. However, the limits of this AM process are minor compared to the 
architectural opportunities it offers, including standardization of bioceramics manufacturing, high 
and reproducible architectural control for a wide range of designs, phase biocompatibility 
preservation and ease of implementation for various phase compositions. All of these advantages 
will allow the development of new tools for experimental/fundamental research that will help to 
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Figure 1. A) Ceramic and B) mold 3D images derived from CAD software, and C) their respective cross-
sections (Bioceramic channels are the negative of the mold columns, and triangles were designed 
with angles θ1 = 45° and θ2 = 90°). Schematic representation of D) the 3D printing technology with an 
adjustable layer thickness along the z-axis of the printer (6, 12, 19, 25 µm), and the printing 







Figure 2. Schematic representation of the “shape” and “morphology” of an object, and the main 
dimensional variables considered for the geometric analysis at the pore scale. 
 
 
Figure 3. 3D X-ray micro-tomography images of bioceramics manufactured from molds printed with a 
12 µm resolution; the x-, y-, z- axes represent the 3D printer axis. Bioceramic from mold printed with 





Figure 4. Influence of the mold printing strategy on the architectural features of the bioceramic 
manufactured from molds printed with columns A- along and B- perpendicular to the z-axis. The x-, y-, 
and z-axes represent the 3D printer axes. A1-A3 and B1-B3 show the measured circles diameters and 
triangles 45° and 90° angles, respectively. Small, medium and large channels are displayed in red, 
blue and green, respectively. Colored bands outline the 99% confidence interval calculated from 
measurements (N=9) with 2
nd




Figure 5. Influence of mold printing parameters on shape factors. The S, M and L symbols refer to the 
small, medium and large channels, respectively. Green, red and blue curves refer to the 25, 12 and 6 
µm resolution used to produce the molds, respectively. The x-, y-, and z-axes represent the printer 
axes. An overview of the general channel shape and parameters considered for the shape factor 




Figure 6. SEM images of the cross-sections of the channels in the bioceramics produced from molds 
printed with columns A, B and C) along and D, E and F) perpendicular to the z-axis of the printer with 




Figure 7. A) 3D image obtained from X-ray micro-tomography of the spherical macroporous 
bioceramics (gyroid internal architecture), B) cross-sections relative to the xy-, xz- and yz-planes 
displayed on the 3D view, and C) comparison of cross-sections of the CAD model (blue) and the 
resulting bioceramic (cyan) at different heights (1/4, 1/2, 2/3) in the sample using Simpleware 
software (The shrinkage of the bioceramic structure was simulated on the CAD file using a 




Figure 8. A) Schematic representation of the technological limitations of the DoD process, where Δd is 
the size variation of the droplet size at the print head outlet, Δp is the deviation of the wax droplet 
from its theoretical position, and Δs is the average diameter of the splashed wax droplet after 
deposition. These wax deposition issues are greatly influenced by the frequency of the piezo-electric 
component Δƒ inside the print-head, the print head and operating temperatures, ΔT, as well as the 
print head position and momentum. B) Optical microscopy image of the resulting inaccuracy, Δε = 




Figure 9. Examples of porous HA bioceramics produced by impregnation of 3D-printed wax molds. 
This process allows adjusting the shape, the intern architecture (smallest achievable frame/shape 
(i.e., circle or square) is 120 µm), the surface microtopography (cusp depth and width of 20 µm to 5 







Table 1. Lengths of the flattened surfaces derived from the cropping of the 90° angle in the triangles. 
Measurements (N=9) were carried out on the sliced .stl files and on X-ray micro-tomography images 
of the molds and bioceramics (orientation of the columns/ channels perpendicular to the z-axis of the 
3D-printer). Fig. in the supplementary data complements this table.  
Resolution / µm Shapes 
Flattened surface / µm 
Sliced .stl file Mold Bioceramic 
25 
S Triangle 109.9 155.0 ± 4.0 136.0 ± 21.6 
M Triangle 104.0 159.0 ± 13.1 146.7 ± 13.6 
L Triangle 116.2 180.3 ± 3.1 153.7 ± 9.3 
12 
S Triangle 110.4 139.0 ± 9.6 133.7 ± 10.6 
M Triangle 103.0 134.0 ± 11.5 121.3 ± 14.5 
L Triangle 116.8 170.3 ± 1.5 147.3 ± 12.6 
6 
S Triangle 109.7 129.0 ± 5.3 116.3 ± 5.7 
M Triangle 91.8 135.0 ± 2.0 128.3 ± 2.3 





Supplementary Figure S1. Images produced from CAD software of A. The designed bioceramic with 
the x-, y-, and z-axes representing the 3D printer axes and specific visual markers (in orange) serving 





Supplementary Figure S2. Example of the evolution of shape deformation throughout each stage of 
the bioceramic production process with A. the CAD conception of the mold, B. the tessellation of the 
CAD file (.stl export), C. the slicing of the .stl file with respect to a specific orientation of the part (in 
the current example, mold columns are perpendicular to the z-axis of the printer), D. a cross-section 
of the produced mold imaged with X-ray tomography and E. a cross section of the resulting 
bioceramic imaged with X-ray tomography. 
 
